Abstract
At present, the treatment of unresectable non-metastatic pancreatic cancer remains palliative. In selected patients, aggressive treatment programs of irradiation and chemotherapy may result in median survivals of approximately 12 months and 2-year survival rates of 20%. Long-term survivors are rare. Future efforts will be directed toward evaluation of irradiation with new agents such as paclitaxel and gemcitabine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Moertel CT, Childs DS Jr, Reitemeir RJ, et al.. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;2:865–867.
Gastrointestinal Tumor Study Group. Therapy of locally un- resectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radia- tion (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer 1981;48:1705–1710.
Moertel CG, Frytak S, Hahn RG, et al.. Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma: Gastrointestinal Tumor Study Group. Cancer 1985;56:2563–2568.
Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: Comparison of com- bined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Nad Cancer Inst 1988;80:751–755.
Roldan GE, Gunderson IX, Nagorney DM, Martin JK, II-strup DM, Holbrook MA, Kvols LK, Mcllrath DC. External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer 19S8;61:1110–1116.
Jessup JM, Steele G, Mayer RJ, et al.. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 1993;128:559–564.
Tepper JE, Moyes D, Krall JM, et al.. Intraoperative radiation therapy of pancreatic carcinoma: A report of RTOG-8505. Int J Radiat Oncol Biol Phys 1991;21:1145–1149.
Shipley WU, Nardi GL, Cohen AM. Iodine-125 implant and external beam irradiation in patients’with localized pancreatic carcinoma: A comparative study to surgical resection. Cancer 1980;45:709–714.
Tepper JE, Shipley WU, Warshaw AL, Nardi GL, Wood WC, Orlow EL. The role of misonidazole combined with in- traoperative radiation therapy in the treatment of pancreatic carcinoma. J Clin Oncol 1987;5:579–584.
Garton GR, Gunderson IX, Nagorney DM, et al.. High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer. Int Radiat Oncol Biol Phys 1993;27:1153–1157.
Safran H, King T, Choy H, et al.. Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: A phase I study. J Clin Oncol 1997;15:901–907.
Burris H, Moore M, Anderson J, et al.. Improvements in sur- vival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: A randomized trial. J Clin Oncol 1997;6:2403–2413.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Willett, C.G. Irradiation for unresectable pancreatic cancer. J Gastrointest Surg 3, 351–353 (1999). https://doi.org/10.1016/S1091-255X(99)80049-3
Issue Date:
DOI: https://doi.org/10.1016/S1091-255X(99)80049-3